Skip to content

Analgesic Effects of US Bilateral Rectus Sheath Block for Laparoscopic GY Surgery

Postoperative Analgesic Effects of Ultrasound-guided Bilateral Rectus Sheath Block for Laparoscopic Gynecologic Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02476799
Enrollment
60
Registered
2015-06-19
Start date
2014-11-30
Completion date
2015-05-31
Last updated
2015-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Disease

Brief summary

Rectus sheath block (RSB) is a kind of anterior abdominal wall block. It has postoperative analgesic effect for abdominal surgery with midline incision. Laparoscopic gynecologic surgery is accompanied by significant postoperative pain and usually IV-PCA is used to manage the pain.The purpose of this study is to investigate the analgesic effect of ultrasound-guided RSB to multi-port laparoscopic gynecologic surgery which has incision site at umbilical area. Patients will randomly assigned to two groups, RSB group and Control group. Each patients will assessed for time to first rescue analgesia, verbal numerical rating pain scores, number of rescue analgesic demands, and postoperatively opioids use by IV-PCA by a blinded investigator at 0, 1, 6, 12, 24 and 48 hours postoperatively.

Detailed description

Patients of RSB group will be performed ultrasound-guided bilateral RSB after induction of general anesthesia. The procedure will be performed bilaterally and 15 ml on each side, total 30 ml of 0.25% ropivacaine will be injected. After the procedure, a surgery scheduled will be proceeded. Patient of Control group will be proceeded the surgery after induction of anesthesia. All patients will use total 100 ml of IV-PCA containing 800 µg of fentanyl with 150 mg of ketorolac for 48 hours postoperatively. If a patient complains pain more intense than VNRS 4 or demands an analgesic drug, a rescue analgesic would be allowed.

Interventions

PROCEDURERectus sheath block

Ultrasound-guided bilateral rectus sheath block of RSB group using 0.25% Ropivacaine

DRUGRopivacaine

Ultrasound-guided bilateral rectus sheath block of RSB group using 0.25% Ropivacaine

OTHERBandage

After the surgery, a bandage will be attached on injection site where is same as the incision site of surgery.

DRUGIV-PCA containing Fentanyl and Ketorolac

All patients will use total 100 ml of IV-PCA containing 800 µg of fentanyl and 150 mg of ketorolac for 48 hours postoperatively.

Sponsors

Ewha Womans University Mokdong Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Multi-port laparoscopic gynecologic surgery * American society of Anesthesiologists (ASA) physical status classification I-II * Age: 21-60

Exclusion criteria

* Gynecologic cancer operation * History of previous abdominal surgery * Allergy to local anesthetics(ropivacaine) * Opioid tolerance * Coagulopathy * Infection at the needle insertion site * Difficulty to cooperating

Design outcomes

Primary

MeasureTime frameDescription
Number of rescue analgesics48 hours postoperativelyNumber of injected additional NSAIDs other than IV-PCA for 48 hours postoperatively

Secondary

MeasureTime frameDescription
Total opioids useTime Frame: 0, 1, 6, 12, 24, 48 hours postoperativelyTotal dosage of injected fentanyl through IV-PCA
Time to first rescue analgesic request48 hours postoperativelyHow long it takes postoperative time to first additional analgesic drug injection by patient's request
Postoperative pain measured on the verbal numerical rating scale0, 1, 6, 12, 24, 48 hours postoperativelyPostoperative pain on each time point which is expressed by verbal numerical rating scale (0 \ 10)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026